Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341.
Fang Y, Hu Y, Wu P, Wang B, Tian Y, Xia X, Zhang Q, Chen T, Jiang X, Ma Q, Xu G, Wang S, Zhou J, Ma D, Meng L.
Fang Y, et al. Among authors: hu y.
Cancer Invest. 2011 May;29(4):247-52. doi: 10.3109/07357907.2010.496756. Epub 2011 Feb 23.
Cancer Invest. 2011.
PMID: 21345073
Free article.